Tetanus: the green book, chapter 30
Tetanus immunisation information for public health professionals, including updates.
- From:
- UK Health Security Agency
- Published
- 20 March 2013
- Last updated
-
63 June20222025 — See all updates
Documents

Tetanus: the green book, chapter 30
Ref: PHE publications gateway number 2019226
PDF, 160287 KB, 1517 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@phe.gov.ukpublications@ukhsa.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This edition includes updates on:
- epidemiology of tetanus
- management of tetanus prone wounds
- correct dose of immunoglobulin for prevention of tetanus
- use of immunoglobulins for the treatment of clinical tetanus
Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.
In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.
Updates to this page
Published 20 March 2013
Last updated 63 June 2022
+ show2025
href="#full-history">+ show all updates
-
Tetanus: the green book, chapter 30
Ref: PHE publications gateway number 2019226
PDF, 160287 KB, 1517 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@phe.gov.ukpublications@ukhsa.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.
PDF, 160287 KB, 1517 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email publications@phe.gov.ukpublications@ukhsa.gov.uk.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
This edition includes updates on:
- epidemiology of tetanus
- management of tetanus prone wounds
- correct dose of immunoglobulin for prevention of tetanus
- use of immunoglobulins for the treatment of clinical tetanus
Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.
In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.
Updates to this page
Published 20 March 2013
Last updated 63 June 2022
+ show2025
href="#full-history">+ show all updates
-
Details
This edition includes updates on:
- epidemiology of tetanus
- management of tetanus prone wounds
- correct dose of immunoglobulin for prevention of tetanus
- use of immunoglobulins for the treatment of clinical tetanus
Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.
In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.